Skip to content

PMN

ProMIS Neurosciences, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$8.23
+0.98%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue———10.4M—
Gross Profit———(10.4M)—
Operating Expenses
R&D Expense35.7M33.4M10.6M7.9M16.1B
SG&A Expense7.8M6.8M6.2M6.4M7.3B
General & Admin Expense6.4M6.8M6.2M7.4M7.3B
Selling & Marketing Expense———(1.0M)—
Other Expenses———(5.8M)—
Total Operating Expenses43.4M40.2M16.8M8.5M23.4B
Cost and Expenses43.4M40.2M16.8M18.9M23.4B
Operating Income (EBIT)(43.4M)(40.2M)(16.8M)(18.9M)(23.4B)
Non-Operating
Interest Income—————
Interest Expense——76.8K201.4K282.1M
Net Interest Income——(76.8K)(201.4K)(282.1M)
Other Non-Op Income/Expense1.2M448.2K19.6M1.4M5.3B
Non-Operating Income (excl Interest)(707.0K)(448.2K)(19.7M)(1.1M)(5.6B)
EBT (Pre-Tax Income)(42.2M)(39.7M)2.8M(17.5M)(18.1B)
Income Tax Expense—————
Bottom Line
Net Income(42.2M)(39.7M)2.8M(17.5M)(18.1B)
Earnings from Cont. Ops(42.2M)(39.7M)2.8M(17.5M)(18.1B)
Earnings from Discont. Ops—————
Bottom Line Net Income(42.2M)(39.7M)2.8M(17.5M)(18.1B)
Per Share
Basic EPS($16.89)($22.61)$2.75($35.50)($60.25)
Diluted EPS($16.89)($22.61)$2.75($35.50)($60.25)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding9.1M1.8M1.0M491708300104
Diluted Shares Outstanding9.1M1.8M1.1M491708300104
Profitability Metrics
EBITDA(42.7M)(39.7M)2.9M(17.8M)(17.8B)
D&A———21.2K14.4K
EBIT(42.7M)(39.7M)2.9M(17.8M)(17.8B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026